Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for CRSP stands at 63.182, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 1.642, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 94.263 and the Commodity Channel Index (CCI) at 145.978 further confirm a 7.7 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, CRSP is trading below its 60-day moving average of $54.71 and below its 200-day long-term moving average of $54.877. Key price levels to watch include the immediate resistance at $61.426 and strong support at $51.586. A break above $61.426 could signal a bull continuation, while falling below $51.586 may test the next Fibonacci floor at $46.833.

CRISPR Therapeutics AG (CRSP) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	41.746	46.833	51.586	56.673	61.426	66.513	71.266
Fibonacci	46.833	50.592	52.914	56.673	60.432	62.754	66.513

CRISPR Therapeutics AG (CRSP) Technical Indicators

2026-03-02

Name	Value
RSI_14	63.182
STOCHk_14_3_3	94.263
STOCHd_14_3_3	90.727
CCI_20	145.978
AO_5_34	4.432
MOM_10	7.7
MACD_12_26_9	1.642

CRISPR Therapeutics AG (CRSP) Relative Strength Index (RSI) is 63.182, creating a Neutral signal.

CRISPR Therapeutics AG (CRSP) Stochastic Oscillator is 94.263, creating a Sell signal.

CRISPR Therapeutics AG (CRSP) Stochastic RSI is 90.727, creating a Sell signal.

CRISPR Therapeutics AG (CRSP) Commodity Channel Index (CCI) is 145.978, creating a Sell signal.

CRISPR Therapeutics AG (CRSP) Awesome Oscillator is 4.432, creating a Buy signal.

CRISPR Therapeutics AG (CRSP) Momentum is 7.7, creating a Buy signal.

CRISPR Therapeutics AG (CRSP) MACD is 1.642, creating a Buy signal.

CRISPR Therapeutics AG (CRSP) Moving Average

2026-03-02

Period	Simple	Signal
MA_5	58.924	Buy
MA_10	56.339	Buy
MA_20	53.017	Buy
MA_60	54.71	Buy
MA_200	54.877	Buy
MA_250	51.589	Buy

CRISPR Therapeutics AG (CRSP) 5-Day simple moving average is 58.924, while CRISPR Therapeutics AG (CRSP) share price is $60.77, making it a Buy.

CRISPR Therapeutics AG (CRSP) 10-Day simple moving average is 56.339, while CRISPR Therapeutics AG (CRSP) share price is $60.77, making it a Buy.

CRISPR Therapeutics AG (CRSP) 20-Day simple moving average is 53.017, while CRISPR Therapeutics AG (CRSP) share price is $60.77, making it a Buy.

CRISPR Therapeutics AG (CRSP) 60-Day simple moving average is 54.71, while CRISPR Therapeutics AG (CRSP) share price is $60.77, making it a Buy.

CRISPR Therapeutics AG (CRSP) 200-Day simple moving average is 54.877, while CRISPR Therapeutics AG (CRSP) share price is $60.77, making it a Buy.

CRISPR Therapeutics AG (CRSP) 250-Day simple moving average is 51.589, while CRISPR Therapeutics AG (CRSP) share price is $60.77, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for CRSP?

The overall technical consensus for CRISPR Therapeutics AG (CRSP) is currently Strong Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 4 sell signals.

What are the key support and resistance levels for CRISPR Therapeutics AG (CRSP) today?

Based on pivot point calculations, CRISPR Therapeutics AG (CRSP) has an immediate support level at 51.586 and a major resistance level at 61.426. Traders also monitor the pivot point at 56.673 to determine the intraday trend direction.

Is CRISPR Therapeutics AG (CRSP) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for CRISPR Therapeutics AG (CRSP) is currently 63.182. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for CRISPR Therapeutics AG (CRSP)?

CRISPR Therapeutics AG (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 1.642, suggesting CRSP is Strong Buy. This indicator helps identify potential trend reversals or momentum shifts for CRISPR Therapeutics AG.

How is CRISPR Therapeutics AG (CRSP) performing relative to its 200-day moving average?

CRISPR Therapeutics AG (CRSP) is currently trading at $60.77, which is above its 200-day simple moving average of 54.877. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.

CRSP Technical

CRSP Technical

Technical Sentiment

Overall Consensus

Technical Analysis Consensus

Moving Average Consensus

Technical Analysis for CRSP